ACC Highlights: Better Stents, But Are Stents Often Necessary?
Executive Summary
The 56th Annual American College of Cardiology conference provided the expected clinical trial updates on a variety of interventional devices. But the most anticipated and surprising news of the meeting came from the COURAGE study, whose results broke against the tide of using interventional procedures and stents as primary therapy for stable coronary artery disease.
You may also be interested in...
AHA Highlights: Improving Patient Care
The American Heart Association's scientific sessions in November 2007 presented new clinical data on drug-eluting stents, cardiac resynchronization, treatments for acute coronary syndrome, and better ways of diagnosing and treating myocardial infarction.
AHA Highlights: Improving Patient Care
The American Heart Association's scientific sessions in November 2007 presented new clinical data on drug-eluting stents, cardiac resynchronization, treatments for acute coronary syndrome, and better ways of diagnosing and treating myocardial infarction.
Stent Recap: Turmoil in 2007--What's Ahead for Interventional Cardiology?
Although safety concerns about drug-eluting stents have been mitigated somewhat by recent reports of more positive clinical data, there is lingering unease and confusion in the cardiology community about when, how, and in whom to use these devices. There is also a growing wave of healthy skepticism about the way stent trials are designed and conducted, and whether evidence- based medicine is well served by the current process.